Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a…
Doctors think AI has a place in healthcare – but maybe not as a chatbot
Dr. Sina Bari, a practicing surgeon and AI healthcare leader at data company iMerit, has seen firsthand how…
Fruit fly study identifies genes regulating dopamine and sleep
Dopamine in the brain influences movement, learning, motivation and sleep. In humans, problems with dopamine are linked to…
New research identifies faulty TRPM3 ion channel in ME/CFS immune cells
A faulty ion channel function is a consistent biological feature of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), providing long-awaited…
Mental health treatment a growing concern in Illinois jails
Despite repeated warnings from medical professionals, staff at the Sangamon County Jail placed 27-year-old Tiffany Rusher — who…
Is there a best time of day to take vitamins?
C-ing is B-elieving — supplements are everywhere these days. Over 100,000 dietary or nutritional supplements are sold in…
Research finds persistent prescribing of risky medications to older adults with dementia
Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is prescribed…
Researchers develop automatic tool to prevent hip dislocation in children with Cerebral Palsy
Researchers from the Universities of Manchester and Liverpool, together with Manchester Imaging Ltd, (a local company that specialises…
‘The Pitt’ creator on Season 2’s storylines about AI, healthcare costs
R. Scott Gemmill, the creator and showrunner of “The Pitt,” has always felt comfortable in a hospital. He…
iHerb acquires Vitacost to accelerate U.S. market presence
“This is an exciting and highly complementary acquisition for iHerb,” said Emun Zabihi, chief executive officer of iHerb,…
Durvalumab extends survival in small cell lung cancer but raises cost concerns
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living…
Real-time smartphone monitoring improves evaluation of insomnia treatment effectiveness
About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and…